STING1 and neoplasm: developed membrane-coated nanocomposites that mimicked tumor membranes, enhanced immune recognition, and blocked efferocytosis while activating the cGAS/STING pathway, thereby extending survival in melanoma models and enhancing PD-1 inhibitor efficacy (43).